53.58 +0.00 (0.00%)
NVS
Stock Details
Last Trade:53.58 Change:+0.00 (0.00%) Prev Close:53.58 Open: 53.23 Days Range:53.06 – 53.79 52 Week Range: 33.34 - 56.42 Volume:2507700 P/E: N/AEPS:0.00
View AllRecent Alerts 02/10/10
Recent Alert on 02/09/10 at 9:11am
Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb
Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb
Novartis (NYSE: NVS) has gained exclusive rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the first in a new class of... Read More
Recent Alert on 02/09/10 at 9:11am
Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb
Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb
Recent Alert on 02/08/10 at 7:09am
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
Recent Alert on 02/08/10 at 7:09am
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
SciClone Pharma (SCLN) and Partner Announce Topline Results for ZADAXIN
View AllRecent Press Releases
No Recent Press Releases Available